Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
07 2019
Historique:
entrez: 31 5 2019
pubmed: 31 5 2019
medline: 4 7 2020
Statut: ppublish

Résumé

Although several risk factors for retinal vein occlusion (RVO) are known, what triggers RVO is unclear in many cases. We aimed to evaluate the relevance of multiple risk factors in patients with RVO. The Gutenberg RVO Study is an observational case-control study that assessed thrombophilic, cardiovascular, ophthalmic, and drug-related risk factors in participants with RVO and the same number of matched controls. Conditional logistic regression analysis was chosen to estimate the risk of RVO due to several risk factors. Of 92 patients with RVO, 46 (50%) had central RVO, 31 (33.7%) had branch RVO, and 15 (16.3) had hemi-RVO. Systemic hypertension was associated with RVO [any RVO: odds ratio (OR): 1.81; 95% confidence interval (CI): 1.14-2.88; branch RVO: OR: 2.56; 95% CI: 1.08-6.10]. The most frequent combinations of risk factors were hypertension with dyslipidemia (33 of 92, 35.9%) and hyperhomocysteinemia and high levels of factor VIII (10 of 92, 10.9%). An increase in the risk sum score by one additional risk factor corresponded to ORs of 1.74 (95% CI: 1.31-2.32) for cardiovascular risk factors, 1.38 (95% CI: 1.04-1.82) for thrombophilic risk factors, and 1.43 (95% CI: 1.20-1.70) for the total number of risk factors for RVO. Cardiovascular risk factors are more important than other risk factors for the presence of RVO. The risk of RVO increased by approximately 40% with any additional risk factor and by 70% with any additional cardiovascular risk factor.

Identifiants

pubmed: 31145709
doi: 10.1097/HJH.0000000000002057
pii: 00004872-201907000-00010
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1372-1383

Auteurs

Katharina A Ponto (KA)

Department of Ophthalmology.
Center for Thrombosis and Hemostasis.

Inge Scharrer (I)

Department of Medicine III (Hemostaseology).

Harald Binder (H)

Division of Biostatistics and Bioinformatics, Institute of Medical Biostatistics, Epidemiology and Informatics.
Faculty of Medicine and Medical Center, Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg im Breisgau.

Christina Korb (C)

Department of Ophthalmology.

Ann K Rosner (AK)

Department of Ophthalmology.
Department of Anesthesiology.

Till O Ehlers (TO)

Department of Ophthalmology.

Nikola Rieser (N)

Department of Ophthalmology.

Nadja C Grübel (NC)

Department of Ophthalmology.

Heidi Rossmann (H)

Institute of Clinical Chemistry and Laboratory Medicine.

Philipp S Wild (PS)

Center for Thrombosis and Hemostasis.
Preventive Cardiology and Preventive Medicine, Center for Cardiology.
DZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, University Medical Center, Mainz.

Nicolas Feltgen (N)

Faculty of Medicine and Medical Center, Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg im Breisgau.

Norbert Pfeiffer (N)

Department of Ophthalmology.

Alireza Mirshahi (A)

Department of Ophthalmology.
Department of Ophthalmology, University Medical Center Göttingen, Göttingen.
Dardenne Eye Hospital, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH